VACCINEXPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.83 USD | -1.70% |
|
+19.96% | -37.36% |
| 04-12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
| 04-02 | Vaccinex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar VACCINEXPAR
84b8a4f4ec897128b4df314.lue3koch8rJZsubwzKleQCbsN5FPziuedQehzsjy1Ao.3Yre6rNXgucJgoOChcMJD0WGVPI6hV_zBHXqtpiqo1mmhtj0znC42hHdvw~364a634efcbbae0f61f53c89f687688a
Upcoming events on VACCINEXPAR
No events available
Past events on VACCINEXPAR
| 2023-11-13 08:00 | Q3 2023 Earnings Release |
| 2023-11-03 | Society for Immunotherapy of Cancer Meeting |
| 2023-11-03 09:00 | Society for Immunotherapy of Cancer Meeting |
| 2023-10-23 | Clinical Trials on Alzheimer Disease conference |
| 2023-09-30 | Keystone Symposium |
| 2023-09-29 16:40 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 2023-09-28 08:35 | CHI Discovery on Target conference |
| 2023-09-26 | AACR Special Conference in Cancer Research: Pancreatic Cancer |
| 2023-09-08 08:30 | Extraordinary Shareholders Meeting |
| 2023-08-14 08:10 | Q2 2023 Earnings Release |
| 2023-06-09 10:00 | Jefferies Global Healthcare Conference |
| 2023-06-04 | BIO International Convention |
| 2023-06-01 | American Society of Clinical Oncology Conference |
| 2023-05-15 16:45 | Q1 2023 Earnings Release |
| 2023-05-14 | PEGS Boston Summit |
| 2023-05-10 | Annual General Meeting |
| 2023-04-03 08:00 | Q4 2022 Earnings Release |
| 2023-03-24 14:00 | AAIC Advancements Immunity Conference |
| 2022-11-14 08:30 | Q3 2022 Earnings Release |
| 2022-11-11 17:20 | Society for Immunotherapy of Cancer Meeting - Abstract No - 613 |
Annual results
| Fiscal Period | December | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,52 0,57 -7.6% | 0,63 0,62 1.63% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -32,0 -34,5 7.16% | -28,3 -31,4 9.69% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
|
Net income Million USD | Released Forecast Spread | -31,9 -34,4 7.28% | -28,9 -31,5 8.27% |
|
EPS USD | Released Forecast Spread | -519 -558 6.97% | -323 -341 5.23% |
| Announcement Date | 09/03/20 | 31/03/21 |
Past sector events for VACCINEXPAR
- Stock Market
- Equities
- VCNX Stock
- Calendar VACCINEXPAR
